About us

Volta Medical is a data-inspired, AI solutions electrophysiology company, whose mission is to aid in the treatment of complex heart rhythm disease.

Founded in 2016 by a data scientist and 3 electrophysiologists.

Strong AI product pipeline; proven data collection, curation & labeling capabilities.

Proven track-record in running large scale international clinical trials.

Total capital raised over €90M.

Our Investors & Partners

Key events timeline
2016
Volta Medical is founded by a data scientist, Théophile Mohr Durdez and three electrophysiologists: Dr. Julien Seitz, Dr. Jérôme Kalifa and Dr. Clément Bars.
NOVEMBER
Seed Series €2.6M - Lead Investor Groupe Pasteur Mutualité
2018
JULY
First patient included in the Ev-AIFib Study
2019
APRIL
Deep Tech Award
2020
JANUARY
VX1 CE Marked
SEPTEMBER
VX1 FDA Cleared
OCTOBER
First Commercial Case
NOVEMBER
Series A €23M - Lead Investor Gilde Healthcare
2021
FEBRUARY
First patient included in the Tailored AF-Study
2022
SEPTEMBER
Publication of the EV-AIFib Study
2023
JANUARY
Series B €36M - Lead Investor Vensana Capital

Volta AF-Xplorer™ FDA Cleared
FEBRUARY
Completion of Patient Enrollment in the Tailored-AF trial
JUNE
Initiation of the RESTART Clinical Trial
OCTOBER
Best Startup Prix Galien Award
2024
FEBRUARY
Volta AF-Xplorer™ CE Marked
MAY
Presentation of Tailored-AF results

Laureate of the French Tech 120
The future is bright. Check back for our future milestones !

Our latest news

May 2024

Volta Medical presents results from the first transatlantic randomized controlled trial comparing AI-assisted ablation procedure with the conventional treatment for persistent atrial fibrillation patients

Read Article
May 2024

Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation

Read Article
April 2024

Volta Medical Announces Late-Breaking TAILORED-AF Randomized Clinical Trial Results at Heart Rhythm 2024 in Boston, MA, USA

Read Article
February 2024

Volta Medical Receives CE Mark for AF-Xplorer™ Decision support solution to Simplify Complex Atrial Fibrillation Procedures

Read Article
November 2023

Volta Medical Named Best Startup at Prix Galien USA Awards 2023

Read Article
June 2023

Volta Medical Announces Initiation of RESTART Clinical Trial for Treatment of Repeat Atrial Fibrillation

Read Article
May 2023

Volta Medical Announces FDA Clearance of Volta AF-Xplorer™ Software to Simplify Complex Atrial Fibrillation Procedures.

Read Article
February 2023

Volta Medical Announces Completion of Patient Enrollment in TAILORED-AF Clinical Trial for Treatment of Atrial Fibrillation.

Read Article
January 2023

Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced.

Read Article
September 2022

Volta Medical's AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication.

Read Article